Moderna Stock: How COVID Vaccine Drove Biotech’s Wild Ride
<h2>Moderna’s Stock Performance Reflects Global Vaccine Demand and Scientific Ambition</h2> <p>Moderna, once a relatively obscure biotech firm, became a household name during the COVID-19 pandemic. Its mRNA vaccine, developed in record time, played a pivotal role in global immunization efforts. The company’s stock price surged as governments and health organizations scrambled to secure doses, turning…
